Tumores Gastrintestinais
Opinião de especialistas sobre o tratamento da insuficiência pancreática exócrina no câncer pancreático.
8 Fev, 2022 | 14:34hExpert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer – ESMO Open
Estudo randomizado | Em pacientes com carcinoma esofágico de células escamosas avançado, tanto o nivolumabe com quimioterapia quanto o nivolumabe com ipilimumabe resultaram em sobrevida geral mais longa do que a quimioterapia isolada.
4 Fev, 2022 | 16:48hNivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário (Reunião anual da ASCO 2021): Nivolumab Plus Chemotherapy and Nivolumab Plus Ipilimumab as First-Line Treatment for Patients With Advanced Esophageal Cancer – The ASCO Post
Comentário no Twitter
First-line treatment of advanced esophageal squamous-cell carcinoma with either nivolumab plus chemo or nivolumab plus ipilimumab resulted in a significant overall survival benefit and durable responses as compared with chemo alone. https://t.co/a000bDsh1N pic.twitter.com/NuY2eX58gp
— NEJM (@NEJM) February 2, 2022
M-A | Gastrectomia distal laparoscópica vs. aberta para câncer gástrico.
4 Fev, 2022 | 16:29hRevisão | Malignidades peritoneais primária e metastática.
4 Fev, 2022 | 15:51hPrimary and metastatic peritoneal surface malignancies – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)
Infográfico: Primary and metastatic peritoneal surface malignancies – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)
Comentário no Twitter
Treatment modalities for #peritoneal surface malignancies can be combined or used sequentially according to underlying #tumour type, disease extent and patients' condition and preference.https://t.co/cIkVAJRSaj pic.twitter.com/PUP1BtoTxE
— Nature Reviews Disease Primers (@DiseasePrimers) December 21, 2021
M-A | Características clínicas e endoscópicas associadas com câncer gastrintestinal superior pós-endoscopia.
28 Jan, 2022 | 16:44hClinical and Endoscopic Characteristics Associated with Post-Endoscopy Upper Gastrointestinal Cancers: a Systematic Review and Meta-analysis – Gastroenterology (link para o resumo – $ para o texto completo)
Resultados de longo prazo de estudo randomizado | Quimioterapia neoadjuvante vs. cirurgia inicial para câncer pancreático ressecável ou ressecável limítrofe.
28 Jan, 2022 | 16:39hNeoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)
Revisão | Tratamento de metástase peritoneal de pacientes com câncer colorretal.
28 Jan, 2022 | 15:05hTreatment for Peritoneal Metastasis of Patients With Colorectal Cancer – Annals of Coloproctology
Revisão | Características genotípicas e fenotípicas do câncer colorretal hereditário.
28 Jan, 2022 | 15:04hGenotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer – Annals of Coloproctology
Estudo randomizado | A adição de trastuzumabe à quimioterapia neoadjuvante para câncer esofágico com superexpressão de HER-2 não melhorou os desfechos.
25 Jan, 2022 | 11:35hTrastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial – The Lancet Oncology (link para o resumo – $ para o texto completo)
Comentário no Twitter
In a phase III trial in 203 pts with HER2+ oesophageal cancer, adding trastuzumab to neoadjuvant CRT did not significantly improve mDFS (19.6 vs 14.2 months; HR 0.99; P = 0.97). The incidence of grade 3 and 4 TRAEs was 43% & 21% vs 54% & 22%: https://t.co/wx0NmVMyCR #esocsm
— NatureRevClinOncol (@NatRevClinOncol) January 21, 2022
Diretriz clínica ASTRO sobre radioterapia externa para câncer hepático primário.
20 Jan, 2022 | 22:01hArtigo original: External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline – Practical Radiation Oncology